• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Arvinas Inc (NQ: ARVN )

26.90 +0.47 (+1.78%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 604,079
Open 26.79
Bid (Size) 26.50 (5)
Ask (Size) 27.50 (5)
Prev. Close 26.43
Today's Range 25.76 - 27.00
52wk Range 14.02 - 53.08
Shares Outstanding 68,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update
October 30, 2024
From Arvinas Inc.
Via GlobeNewswire
What's Next: Arvinas's Earnings Preview
October 29, 2024
Via Benzinga

Performance

YTD
-35.18%
-35.18%
1 Month
+9.89%
+9.89%
3 Month
+7.95%
+7.95%
6 Month
-16.62%
-16.62%
1 Year
+53.54%
+53.54%

More News

Read More
Arvinas Gives Back to Local Greater New Haven Community in Third Annual Impact Day
October 22, 2024
From Arvinas Inc.
Via GlobeNewswire
Arvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024
October 21, 2024
From Arvinas Inc.
Via GlobeNewswire
Critical Insights From Arvinas Analyst Ratings: What You Need To Know
September 09, 2024
Via Benzinga
The Latest Analyst Ratings For Arvinas
July 31, 2024
Via Benzinga
Analyst Ratings For Arvinas
May 17, 2024
Via Benzinga
Arvinas to Participate in Upcoming Investor Conferences
August 29, 2024
From Arvinas Inc.
Via GlobeNewswire
ARVN Stock Earnings: Arvinas Beats EPS, Beats Revenue for Q2 2024
July 30, 2024
Via InvestorPlace
Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update
July 30, 2024
From Arvinas Inc.
Via GlobeNewswire
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
July 22, 2024
From HOOKIPA Pharma Inc.
Via GlobeNewswire
Biotech Arvinas Stock Earns 82 RS Rating
July 17, 2024
Via Investor's Business Daily
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 16, 2024
Via Benzinga
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
July 16, 2024
Via Benzinga
Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer
June 24, 2024
From Arvinas Inc.
Via GlobeNewswire
Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2
June 21, 2024
From Arvinas Inc.
Via GlobeNewswire
Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer
June 17, 2024
From Arvinas Inc.
Via GlobeNewswire
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains
June 14, 2024
Via Talk Markets
Arvinas to Participate in Upcoming Investor Conferences
June 03, 2024
From Arvinas Inc.
Via GlobeNewswire
Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress
May 23, 2024
From Arvinas Inc.
Via GlobeNewswire
Walmart Posts Upbeat Earnings, Joins Canada Goose, Lightspeed Commerce And Other Big Stocks Moving Higher On Thursday
May 16, 2024
Via Benzinga
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
May 16, 2024
From Arvinas Inc.
Via GlobeNewswire
NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday
May 15, 2024
Via Benzinga
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
May 09, 2024
From Arvinas Inc.
Via GlobeNewswire
ARVN Stock Earnings: Arvinas Beats EPS, Misses Revenue for Q1 2024
May 07, 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap